Welcome to NextGen Pharma
Our commitment to advancing health, happiness and Wellbeing is driven by innovation, particularly in the realms of Probiotics (a targeted-bacteriotherapy approach to many diseases), Postbiotics and Phyto-solutions.
Founded in the commercial operations year of 2015-16, NextGen Pharma, a majority-owned subsidiary of Ormendes SA, Switzerland, has emerged as a leading provider of specialized botanical and nutraceutical solutions. With a focus on proprietary Targeted Bacterio-Therapy (TBT), our offerings cater to diverse therapeutic segments ranging from Gastrointestinal to Neurology.
Gut Microbiome and De Simone Formula (DSF)
We are what we eat was an earlier cliché which is now being replaced with “We are what our Gut Microbiota is”
The bacterial, viral, protozoal cells harbored within the human gastrointestinal tract (GIT) in a synbiotics relation, outnumber the host’s cells by a factor of 10. Human digestive-tract associated microbes are referred to as the gut microbiome / microbiota. Human gut has an estimated, more than 100 trillion bacteria, with an aggregate biomass of approximately 1.5 kg, composed of more than 200 microbial strains in an individual with more than 90% of the dominant bacterial species belonging to the phylum Firmicutes and Bacteroidetes.
Imbalance of the normal gut microbiota / dysbiosis has been linked with gastrointestinal conditions such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), and wider systemic, metabolic manifestations of disease such as obesity, type 2 diabetes, NAFLD and Cognitive conditions such as Autism Spectrum Disorders to Alzheimer’s Disease.
Imbalance of the normal gut microbiota / dysbiosis has been linked with gastrointestinal conditions such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), and wider systemic, metabolic manifestations of disease such as obesity, type 2 diabetes, NAFLD and Cognitive conditions such as Autism Spectrum Disorders to Alzheimer’s Disease.
Empowering care
Presence across key therapeutic segments
Gastrointestinal
Gynecology
Pediatrics
ICU & Critical care
Dental & Oral care
Palliative in Oncology
Dermatology
GI (Anti-piles)
Animal Health
products
Therapeutic Segments
benefits
Why Choose Nextgen Life?
Innovation
We are at the forefront of advancements in Probiotics, Postbiotics and Phyto-solutions for refractory and difficult to treat health conditions.
Quality Assurance
Our products undergo rigorous testing to ensure the highest standards of safety and efficacy.
Personalized Care
Being a B2B company – our unique products are marketed by best of companies for a wider reach.
Scientific Excellence
Backed by extensive clinical studies published in peer reviewed journals, our products provide the best possible outcomes in difficult to treat and meet some of the unmet needs helping physicians.
our Clientele
Building Lasting Relationships
Our Indian Pharma Clients
Our International Pharma Clients
